Prediction of Next-Day Survival in Imminently Dying Cancer Patients: A Multicenter Cohort Study

<b><i>Background:</i></b> Accurate prediction of next-day survival in imminently dying patients is crucial for facilitating timely end-of-life decisions. <b><i>Objectives:</i></b> To develop diagnostic models for predicting next-day survival in cancer patients with a Palliative Performance Scale (PPS) score of ≤20. <b><i>Design:</i></b> A multicenter, prospective, observational study. <b><i>Setting/subjects:</i></b> We enrolled advanced cancer patients at 23 palliative care units across Japan. <b><i>Measurements:</i></b> Clinical signs of impending death were recorded daily after patients' PPS scores decreased to ≤20, continuing until death or for up to 14 days. The developed models included the prediction of one-day survival-decision tree (P1d-Survival-DT), based on recursive partitioning analysis, the P1d-Survival-organ system score, which utilized a scoring system across four clinical systems (nervous/cardiovascular/respiratory/musculoskeletal), and the early signs model that focused on the absence of two early signs (altered consciousness and liquid dysphagia). <b><i>Results:</i></b> Of the 1896 patients included in the study, 1396 (74%) reached PPS ≤20. The average age was 73 ± 12 years, with 49% being female. The P1d-Survival-DT model showed next-day survival rates of 91.6% for patients with a response to verbal stimuli and no peripheral cyanosis, and 37.1% for those with no response to verbal stimuli and respiration with mandibular movement. The P1d-Survival-organ system score model revealed a 95.9% survival rate for score = 0, decreasing progressively to 46.7% for score = 4. The early signs model predicted a 95.2% survival rate in patients with normal consciousness and no liquid dysphagia. <b><i>Conclusions:</i></b> This study successfully developed three distinct models to predict next-day survival in cancer patients with PPS ≤20, offering vital tools for informed decision making in palliative care settings.